HIV/Aids

12 March 2013

One step closer to HIV cure

Australian researchers have moved a step closer to finding a cure for HIV by successfully luring the dormant virus out of hiding in infected cells, a South African university said on Tuesday.

1

Australian researchers have moved a step closer to finding a cure for HIV by successfully luring the dormant virus out of hiding in infected cells, a South African university said.

"New research has shown how the cancer drug vorinostat is able to 'wake up' the sleeping virus that silently persists in patients on standard HIV treatment, by altering how HIV genes are turned on and off," said Monash University.

The university's infectious diseases department head, Prof Sharon Lewin who is also a director of the infectious diseases unit at Alfred Hospital in Melbourne, felt the trial results were promising and would inform further studies into curing HIV.

How the research was done

"We know the virus can hide in cells and remain out of reach from conventional HIV therapies and the immune system," said Lewin, who also co-heads the centre for virology at the Burnet Institute in Melbourne.

"Anti-HIV drugs are unable to eradicate the virus because it burrows deeply into the DNA of immune cells, where it gets stuck and goes to sleep."

Anti-HIV drugs were effective in keeping people healthy, but could not eliminate a dormant virus. "We wanted to see if we could wake the virus up, and using vorinostat we have successfully done that," she said.

Twenty HIV-positive patients in Victoria, Australia, were the first in the world to participate in the vorinostat trial.

"This is a very important step, but the results of the trial have raised further questions," said Lewin. "We've shown we can wake up the virus. Now we need to work out how to get rid of the infected cell. A kick-start to the immune system might help."

Lewin said there was an enormous amount still to learn about how to eradicate a "very smart virus".

Last year, Lewin and her team discovered how the virus, which infects more than 30 million people worldwide, hides dormant in infected cells, placing it out of the reach of conventional treatments and the immune system.

The research is a collaboration between Monash University, the Burnet Institute, The Alfred Hospital, the Peter MacCallum Cancer Centre, and the National Association of People Living With HIV/Aids.

The research was presented at the 20th Annual Conference on Retrovirus and Opportunistic Infections in Atlanta, in the United States.

SAPA

 

Read Health24’s Comments Policy

Comment on this story
1 comment
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria before working for an HIV/AIDS NPO in Soweto for many years. She was named one of the Mail & Guardian's Top 200 Young South Africans in 2012.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules